Details of the Drug

General Information of Drug (ID: DMD2O00)

Drug Name
JNJ-39758979
Indication
Disease Entry ICD 11 Status REF
Asthma CA23 Phase 2 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C11H19N5
Canonical SMILES
CC(C)C1=CC(=NC(=N1)N)N2CCC(C2)N
InChI
InChI=1S/C11H19N5/c1-7(2)9-5-10(15-11(13)14-9)16-4-3-8(12)6-16/h5,7-8H,3-4,6,12H2,1-2H3,(H2,13,14,15)/t8-/m1/s1
InChIKey
COOGVHJHSCBOQT-MRVPVSSYSA-N
Cross-matching ID
PubChem CID
24994634
ChEBI ID
CHEMBL3236549
CAS Number
1046447-90-8
TTD ID
D0M4UZ
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 ClinicalTrials.gov (NCT00946569) A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma. U.S. National Institutes of Health.